Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1991-05-03
1993-01-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514211, 540542, 540547, C07D26720, C07D28116, C07F 96561, A61K 3155
Patent
active
051822725
ABSTRACT:
The present invention provides substituted dibenzoxazepine compounds of Formula I: ##STR1## wherein X is ##STR2## which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
REFERENCES:
patent: 3534019 (1970-10-01), Coyne et al.
patent: 3624104 (1971-11-01), Cusic et al.
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1976-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
patent: 4559336 (1985-12-01), Mueller
patent: 4559337 (1985-12-01), Mueller
patent: 4614617 (1986-09-01), Mueller
Drower, et al., "The Antiociceptive Effects of Prostaglandin Antagonists in the Rat," European Journal of Pharmacology, 133, 249-256 (1987).
J. H. Sanner, "Dibenzoxapzepine Hydrazides as Prostaglandin Antagonists," Intra-Science Chem. Rept., vol. 6, No. 1, 1-9 (1972).
K. Nagarajan, et al., "Synthesis of 10,11-Dihydrodibenz[b,f][1,4]oxazepine Derivatives as Potential Anticonvulsants & Psychotropic Agents" Indian Journal of Chemistry, vol. 24B, 840-844 (1985).
D. E. MacIntyre, et al., "Antagonism of Human Platelet Responses to Stimulatory and Inhibitory Prostaglandins," Prog. Lipid. Res. 20 (1-4), 453-9 (1981).
R. Gimet, et al., "Quantitative Determination of Polymorphic Forms in a Formulation Matrix Using the Near Infra-Red Reflectance Analysis Technique," J. Pharmaceutical & Biomedical Analysis, vol. 5, No. 3, 205-211 (1987).
J. H. Sanner, et al., "Structure-Activity Relationships of some Dibenzoxazepine Derivatives as Prostaglandin Antagonists," Advances in the Biosciences, 9, 139-148 (1972).
A. Rakovska, et al., "Antagonistic Effect of SC-19220 on the Responses of Guinea-Pig Gastric Muscles to Prostaglandins E.sub.1, E.sub.2 and F.sub.2," Arch. Int. Pharmacodyn., 268, 59-69 (1984).
W. E. Coyne, et al., "Anticonvulsant Semicarbazides," J. Med. Chem., 11(6), 1158-1160 (1968).
K. Gyires, et al., "The Use of the Writhing Test in Mice for Screening Different Types of Analgesics," Arch. Int. Pharmacodyn., 267, 131-140 (1984).
A. Bennett, et al., "Antagonism of Prostanoid-Induced Contractions of Rat Gastric Fundus Muscle by SC-19220, Sodium Meclofenamate, Indomethacin or Trimethoquinol," Br. J. Pharmac., 71, 169-175 (1980).
C. A. Maggi, et al., "The Effect of SC-19220, a Prostaglandin Antagonist, on the Micturition Reflex in Rats," European Journal of Pharmacology, 152, 273-279 (1988).
George, et al., "Antagonism of Alcohol Hypnosis by Blockage of Prostaglandin Synthesis and Activity: Genotype and Time Course Effects," Pharmacology Biochemistry & Behavior, vol. 19, 131-136 (1983).
S. Nakajyo, et al., "Inhibitory Effect of Bassianolide, A Cyclodepsipeptide, on Drug-Induced Contractions of Isolates Smooth Muscle Preparations," Japan. J. Pharmacol., 32, 55-64 (1982).
A. Gomes, et al., "Pharmacodynamics of Venom of the Centipede Scolopendra subspinipes dehaani," Indian Journal of Experimental Biology, vol. 20, 615-618 (1982).
Hallinan E. Ann
Husa Robert K.
Peterson Karen B.
Datlow Philip I.
G. D. Searle & Co.
Hastreiter Roberta L.
Matukaitis Paul D.
Shah Mukund J.
LandOfFree
8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1412742